Artivion | CRY - Ebitda



金融业
股票价格
USD
资产
USD 883.16M
现金及等价物
USD 55.76M
销售成本
USD 42.85M
流动资产
USD 357.52M
流动负债
USD 92.7M
债务
USD 317.78M
EBIT
USD 4.79M
EBITDA
USD 22.72M
员工
1.5K
EPS每股收益
USD -0.02
股本和储备
USD 450.47M
销售毛利
USD 73.14M
债务利息支出
USD 5.53M
利息收入
USD -0.05
贷款资金
USD 215.35M
市值
USD 1.11B
净收入
USD 2.42M
营业费用
USD 111.2M
营业利润
USD 4.79M
普通股股本
USD 47.84M
PE价格收益
212.38
税前利润
USD 11.4M
销售收入
USD 115.99M
销售和管理费用
USD 55.75M
股票
USD 98M
贸易债权人
USD 18.34M
应收帐款人
USD 103.68M


Ebitda 更改 日
Abbott USD 2.43B 844M 2026-03
Accuray USD -685K 900K 2024-09
AngioDynamics USD 5.94M 3.78M 2025-09
Artivion USD 22.72M 1.84M 2025-12
AtriCure USD 27.28M 10.21M 2026-06
Baxter International USD 309M 756M 2026-03
Becton, Dickinson and Co. USD 1.71B 433M 2025-12
Boston Scientific USD 1.63B 27M 2026-06
Edwards Lifesciences USD 555.6M 485.5M 2026-03
Integra LifeSciences USD 78.41M 2.23M 2026-06
J&J USD 8.27B 1.08B 2026-03
Mesa Laboratories USD 9.58M 1.47M 2024-09
Orthofix International USD 27.88M 2.77M 2025-12
Pfizer USD 5.99B 5.23B 2026-03
ResMed USD 547.48M 27.46M 2025-12
Stryker USD 1.93B 357M 2026-06
Tandem Diabetes Care USD 2.73M 30.17M 2026-03
Teleflex USD 75.63M 171.44M 2026-03
Terumo JPY 57.88B 12.1B 2026-03
Trinity Biotech USD -9.6M 7.64M 2024-12